This WAIVER AND CONSENT (this “Waiver”) is dated as of September 20, 2012 by and among CHINA CORD BLOOD CORPORATION, an exempted company with limited liability incorporated in the Cayman Islands with its registered office at Codan Trust Company (Cayman) Limited, Cricket Square, Hutchins Drive, PO Box 2681, Grand Cayman KY1-1111, Cayman Islands (the “Company”), and KKR CHINA HEALTHCARE INVESTMENT LIMITED, an exempted company with limited liability incorporated in the Cayman Islands with its registered office at c/o Maples Corporate Services Limited, PO Box 309, Ugland House, Grand Cayman KY1-1104, Cayman Islands (the “Investor”).
CHINA CORD BLOOD CORPORATION
KKR CHINA HEALTHCARE INVESTMENT LIMITED
CONVERTIBLE NOTE PURCHASE AGREEMENT
CHINA CORD BLOOD CORPORATION
GOLDEN MEDITECH HOLDINGS LIMITED
Dated September    , 2012
SECTION 7 CONFIDENTIALITY; RESTRICTION ON ANNOUNCEMENTS
PART D — STRUCTURE CHART OF CHINA CORD BLOOD CORPORATION
CERTIFICATE OF INCUMBENCY AND AUTHORITY
CAYMAN ISLANDS LEGAL OPINION
REGISTRATION RIGHTS AGREEMENT
CONVERTIBLE NOTE PURCHASE AGREEMENT (this “Agreement”) made on September    , 2012
(1)                             CHINA CORD BLOOD CORPORATION, an exempted company with limited liability incorporated in the Cayman Islands with its registered office at Codan Trust Company (Cayman) Limited, Cricket Square, Hutchins Drive, PO Box 2681, Grand Cayman KY1-1111, Cayman Islands (the “Company”); and
(2)                             GOLDEN MEDITECH HOLDINGS LIMITED, an exempted company with limited liability incorporated in the Cayman Islands with its registered office at P.O.
Box 1350, 6T Clifton House, 75 Fort Street, Georgetown, Grand Cayman, Cayman Islands (“Golden Meditech” or the “Investor”).
CSC Holdings owns (i) all of the issued shares of each of China Stem Cells (East) Company Limited, a British Virgin Islands company (“East BVI”), China Stem Cells (West) Company Limited, a British Virgin Islands company (“West BVI”), China Stem Cells (North) Company Limited, a British Virgin Islands company (“North BVI”), China Stem Cells (East) Company Limited, a Hong Kong company (“East HK”), China Stem Cells (West) Company Limited, a Hong Kong company (“West HK”), China Stem Cells (North) Company Limited, a Hong Kong company (“North HK”), and China Stem Cells (South) Company Limited, a Hong Kong company (“South HK”); and (ii) ninety percent (90%) of the issued shares of China Stem Cells (South) Company Limited, a British Virgin Islands company (“South BVI”).
(C)                           CSC Holdings owns one hundred percent (100%) equity interest in Beijing Jiachenhong Biological Technologies Company Limited, a wholly foreign-owned enterprise established in the PRC (“Jiachenhong”).
AGREEMENT:
“KKR” means KKR China Healthcare Investment Limited, an exempted company with limited liability incorporated in the Cayman Islands, affiliated with KKR China Growth Fund L.P., a fund managed by Kohlberg Kravis Roberts & Co. L.P.
“KKR Transaction Documents” means the KKR Convertible Notes Purchase Agreement, dated April 12, 2012, by and between the Company and KKR relating to the KKR Notes and the other documents relating thereto and referred to therein.
“Target Completion Date” means [              ], 2012.
“Agreement”
“CCBS”
“Company”
“CSC Holdings”
“DTC”
“East HK”
“FF HK”
“Indemnified Party”
“Indemnifying Party”
“Investment Value”
“Investor”
“Jiachenhong”
“Nominee Director”
“North HK”
“Shares”
“South HK”
“West HK”
CONFIDENTIALITY; RESTRICTION ON ANNOUNCEMENTS
NEITHER THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE CONVERTIBLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “1933 ACT”), OR UNDER THE SECURITIES LAWS OF ANY OTHER JURISDICTION.
NOTWITHSTANDING THE FOREGOING, THE SECURITIES MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN OR FINANCING ARRANGEMENT SECURED BY THE SECURITIES.
Attention: Christopher S. Auguste
THIS AGREEMENT SHALL BE GOVERNED BY, AND CONSTRUED IN ACCORDANCE WITH, THE LAWS OF THE STATE OF NEW YORK OF THE UNITED STATES APPLICABLE TO CONTRACTS TO BE PERFORMED WHOLLY WITHIN SUCH JURISDICTION, WITHOUT
CHINA CORD BLOOD CORPORATION
GOLDEN MEDITECH HOLDINGS LIMITED
Codan Trust Company (Cayman) Limited,
Director(s) :
Lu Yungang (aka Ken Lu)
China Cord Blood Services Corporation (100%)
Codan Trust Company (Cayman) Limited,
Director(s) :
Codan Trust Company (Cayman) Limited,
Director(s) :
Beijing Jiachenhong Biological Technologies Company Limited (100%) China Stem Cells (East) Company Limited — Incorporated in British Virgin Islands (100%)
China Stem Cells (South) Company Limited — Incorporated in British Virgin Islands (90%)
China Stem Cells (West) Company Limited — Incorporated in British Virgin Islands (100%)
China Stem Cells (North) Company Limited — Incorporated in British Virgin Islands (100%)
China Stem Cells (East) Company Limited — Incorporated in Hong Kong (100%)
China Stem Cells (South) Company Limited — Incorporated in Hong Kong (100%)
China Stem Cells (West) Company Limited —
China Stem Cells (North) Company Limited — Incorporated in Hong Kong (100%)
China Cord Blood Services Corporation (100%)
Box 957, Offshore Incorporations Centre,
Director(s) :
Box 957, Offshore Incorporations Centre,
Director(s) :
Cordlife (Hong Kong) Limited (10%)
Box 957, Offshore Incorporations Centre,
Director(s) :
Box 957, Offshore Incorporations Centre,
Director(s) :
Director(s) :
Director(s) :
Director(s) :
Director(s) :
Director(s) :
China Stem Cells (East) Company Limited (Incorporated in Hong Kong) (83%)
Cordlife Services (S) PTE.
Director(s) :
China Stem Cells (South) Company Limited (Incorporated in British Virgin Islands) (100%)
Director(s) :
Director(s) :
Director(s) :
Director(s) :
STRUCTURE CHART OF CHINA CORD BLOOD CORPORATION
